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LETTER 
To the Editor: 
Scabies, caused by infestation of the Sarcoptes scabiei mite, has been estimated to have a 
prevalence of 146 million people worldwide (GBD 2016 Disease and Injury Incidence and 
Prevalence Collaborators, 2017). A hallmark of scabies is intense itch that worsens at night 
(Jannic et al., 2018). In a study of children and adults with scabies, 94.5% of patients reported 
pruritus (Boralevi et al., 2014). A questionnaire study found an average itch intensity of 7.2 out 
of 10 on the visual analogue scale for scabies patients (Shin et al., 2017). In another study, 36.3% 
of patients described their itch as “intense” or “severe” (Worth et al., 2012). Itch can continue for 
up to four weeks after scabies treatment (Chosidow, 2006) and has important consequences for 
quality of life (Shin et al., 2017, Worth et al., 2012). Additionally, scratching can lead to 
secondary bacterial infection of the skin (impetigo), which can have life-threatening 
complications (Heukelbach and Feldmeier, 2006). However, the molecular mechanisms of 
scabies itch are largely unknown. 
Though histamine is considered the classical pruritogen, most types of chronic itch fail to 
respond to antihistamine treatment. Recent studies have emphasized the importance of 
nonhistaminergic and neural mechanisms in chronic itch conditions (Sanders et al., 2016). The 
ion channels transient receptor potential (TRP) vanilloid 1 (TRPV1) and TRP ankyrin 1 
(TRPA1) are expressed on itch-signaling primary afferent neurons. Tryptase, expressed by mast 
cells, and its receptor protease-activated receptor 2 (PAR-2) are major nonhistaminergic itch 
mediators in diseases like atopic dermatitis. We hypothesized that these mediators may also play 
a role in scabies-related itch. Additionally, numerous dermatoses characterized by itch are known 
to alter epidermal innervation, and such changes may underlie persistent itch following 
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treatment. For this reason, we examined whether epidermal nerve fiber density (ENFD) is altered 
in scabies. An increase in ENFD would indicate thatsc bies induces epidermal hyperinnervation. 
To investigate the potential mechanisms of scabies itch, we collected samples from 
scabies-infested and healthy control skin of pigs and humans. The porcine model of scabies was 
induced as previously described (Bernigaud et al., 2016, Mounsey et al., 2010); see 
Supplementary Materials. Three female Sus scrofa domesticus “large white” pigs were used for 
the experiment. Mite-infested skin crusts were directly transplanted into the ear canal of the 
naive pigs in order to induce a scabies infestation. Biopsies were taken from areas of lesional, 
mite-infested skin and non-lesional (clinically normal in appearance), mite-free skin along the 
back and neck. 
Human samples included de-identified skin biopsies from 6 scabies patients (3 male/3 
female, age 65.00 ± 4.58) and 4 healthy control volunteers (2 male/2 female, age 63.33 ± 10.21). 
Samples were obtained from the University of iami Department of Dermatology & Cutaneous 
Surgery. Biopsies were taken from the abdomen. For scabies patients, diagnosis was confirmed 
by visualization of mites via microscopy of lesional skin adjacent to the tissue used for this 
study. Use of de-identified samples was considered non-human research by the University of 
Miami Institutional Review Board and did not require patient consent. 
Using immunohistochemistry, we quantified the expression of the itch mediators TRPV1, 
TRPA1, PAR-2, tryptase, and histamine in both pig and human samples (see Supplementary 
Materials). We also quantified expression of β-tubulin in order to identify changes in ENFD. 
In the porcine model (Figure 1), epidermal expression of TRPV1, TRPA1, and PAR-2 
was increased in tissue infested with scabies (p=0.031, p<0.0001, and p=0.002, respectively). 
The number of tryptase+ cells near the dermal-epidermal junction was increased in porcine tissue 
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infested with scabies (p=0.021). The number of histamine+ cells did not differ between scabies-
infested and control skin (p=0.73). ENFD did not differ between scabies and control tissue 
(p=0.059). 
In human samples (Figure 2), epidermal expression of TRPV1, TRPA1, and PAR-2 was 
elevated in scabies-infested tissue compared to healthy control (p=0.002, p=0.027, and p=0.010, 
respectively). Furthermore, the number of tryptase+ c lls near the dermal-epidermal junction was 
increased in human tissue infested with scabies (p=0.043). However, the number of histamine+ 
cells near the dermal-epidermal junction was decreased in scabies-infested tissue (p=0.003). 
ENFD was elevated in human skin infested with scabies (p=0.037). 
In conclusion, we found significant elevations of nnhistaminergic itch mediators in the 
skin of a pig model experimentally infested with scabies and of human scabies patients. In both 
species, scabies infestation induced statistically significant elevations in expression of TRPV1, 
TRPA1, and PAR-2 in the epidermis and in the number of tryptase+ cells near the dermal-
epidermal junction. For these results, the pig model showed remarkable similarities to the human 
patients with scabies, suggesting that this model is well suited to study scabies-related itch. The 
slight differences between the pig and human samples (number of histamine+ cells and ENFD) 
may be explained by several possible factors, such as biopsy site, duration of scabies, scratching 
of the skin, or general species differences. Future work will be needed to confirm these results in 
a larger sample size. 
Though antihistamines have been suggested as an adju ct therapy to treat scabies itch 
(Hengge et al., 2006, Mounsey and McCarthy, 2013, Salavastru et al., 2017), our results suggest 
that antihistamine treatment is unlikely to reduce s abies itch. The nonhistaminergic mediators 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 5
we identified are commonly overexpressed in other cronic itch diseases and may provide targets 
for treatment of this severe and bothersome symptom.  
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FIGURE LEGENDS 
Figure 1. Non-histaminergic itch mediators were elevated in porcine skin with 
scabies. (A) Representative images of control (left) or scabies-infested (right) porcine skin 
immunostained for TRPV1, TRPA1, PAR-2, tryptase, histamine, and β-tubulin (n=3). Scale bar 
= 50 µm. Arrows indicate examples of positively stained clls. (B) Quantification of 
immunostaining. Epidermal expression of TRPV1, TRPA1, and PAR-2 was increased in tissue 
infested with scabies. The number of tryptase+ cells was increased in porcine tissue infested with 
scabies. The number of histamine+ cells did not differ between scabies-infested and control skin. 
ENFD, visualized by β-tubulin staining, did not differ between scabies and control tissue. * = 
p<0.05, ** = p<0.01, **** = p<0.001, unpaired t-test cabies vs control. AU = arbitrary units. 
Figure 2. Non-histaminergic itch mediators were elevated in the skin of human 
patients with scabies. (A) Representative images of healthy (left) or scabies-infested (right) 
human skin immunostained for TRPV1, TRPA1, PAR-2, tryptase, histamine, and β-tubulin 
(n=4-6). Scale bar = 50 µm. Arrows indicate examples of positively stained clls. (B) 
Quantification of immunostaining. Epidermal expression of TRPV1, TRPA1, and PAR-2 was 
elevated in scabies-infested tissue compared to healthy control. The number of tryptase+ cells 
was increased in human tissue infested with scabies. The number of histamine+ cells was 
decreased in scabies-infested tissue. ENFD, visualized by β-tubulin staining, was elevated in 
human skin infested with scabies. * = p<0.05, ** = p<0.01, unpaired t-test scabies vs control. 
AU = arbitrary units. 
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